Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture

News (ZH) - Melbourne, 19 September 2024 -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of genomics in agricultural applications.

LGC appoints Dr Alexander Zahiri as Executive Vice President & General Manager, Axolabs

News (ZH) - LGC appoints Dr Alexander Zahiri as Executive Vice President & General Manager, Axolabs

LGC appoints Marcus Kaeller as Chief Financial Officer

News (ZH) - LGC appoints Marcus Kaeller as Chief Financial Officer

Pioneering Cancer Treatments through Enhanced Genomic Profiling

News (ZH) - Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project

NML collaborate to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

News (ZH) - The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning

News (ZH) - LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes 

LGC mid-year Update: 1 April – 30 September 2023

News (ZH) - LGC announces half year trading results

LGC acquires PolyDesign

News (ZH) - LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.   

National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

News (ZH) - National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.  

LGC acquires Virusys Corporation.

News (ZH) - LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.